During the past decade, Eye Center Northeast conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Eye Center Northeast" #1 collaborator was "Novartis" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Eye Center Northeast" are "Dry Eye Syndromes" (3 trials), "Adenoviral Conjunctivitis" (1 trials), "Bacterial Conjunctivitis" (1 trials) and "Keratoconjunctivitis Sicca" (1 trials). Many other conditions were trialed in "Eye Center Northeast" in a lesser frequency.

Most popular intervention types in "Eye Center Northeast" are "Drug" (6 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "PVP-I 0.6%" (2 trials), "Placebo" (2 trials), "SHP640" (2 trials), "cyclosporine" (2 trials) and "REFRESH LIQUIGEL®" (1 trials). Other intervention names were less common.

The vast majority of trials in "Eye Center Northeast" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Eye Center Northeast". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Eye Center Northeast, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Eye Center Northeast, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".